ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 1096 - 1110 of 5996 products
JYSSBio Closes B+ Round for Single-Use Bioreactor Manufacturing
$5.00
Available
Thousand Oaks Bio Completes $235 Million Round for CDMO Ops
$5.00
Available
CARsgen's Claudin18.2 CAR T-Cell Candidate Granted US RMAT Designation
$5.00
Available
Fosun and Insilico Collaborate to Develop Five Candidates
$5.00
Available
Accuredit and N1 Life Form JV to Develop Gene Editing Delivery Technologies
$5.00
Available
Shanghai ZhenGe Completes $100 Million Round for Biologic CDMO Services
$5.00
Available
Sana In-Licenses BCMA CAR Construct from IASO/Innovent in $204 Million Deal
$5.00
Available
Junshi and Coherus Enter $290 Million Agreement for Junshi's TIGIT Antibody
$5.00
Available
Junshi Collaborates With DotBio to Discover Multi-Specific Antibodies
$5.00
Available
Akeso Approved for China Trial of Dual PD-1 Bi-Specifics Therapy
$5.00
Available
Nuance Acquires Sino Health in a Deal Worth at Least $32 Million
$5.00
Available
Clover Bio Starts Construction of R&D Center in Zhangjiang Hi-Tech Park
$5.00
Available
Accro Raises $50 Million for Regulated Cell Death Drug Candidates
$5.00
Available
Jiangsu Atom Closes $45 Million Round for Global Phase III Gout Trial
$5.00
Available
AffaMed Signs $145 Million Agreement for China Rights to Ophthalmic Drug
$5.00
Available